A UK SINGLE CENTRE EXPERIENCE OF MANAGEMENT OF HEPATITIS C VIRUS GENOTYPE 4 INFECTION WITH PEGYLATED-INTERFERON AND RIBAVIRIN

被引：0
|
作者：
Selvapatt, N. [1 ]
Habibi, M. [2 ]
Brown, A. [3 ]
机构：
[1] Univ London Imperial Coll Sci Technol & Med, Dept Hepatol, London, England
[2] Imperial Coll Healthcare NHS Trust, Dept Virol, London, England
[3] Imperial Coll Healthcare NHS Trust, Dept Hepatol, London, England
来源：
GUT | 2015年 / 64卷
关键词：
D O I：
10.1136/gutjnl-2015-309861.223
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PTU-108
引用
收藏
页码：A109 / A109
页数：1
相关论文
共 50 条
  • [1] A European single centre experience of management of hepatitis C virus genotype 4 infection with pegylated-interferon and ribavirin
    Selvapatt, Nowlan
    Habibi, Maximillian S.
    Brown, Ashley
    JOURNAL OF MEDICAL VIROLOGY, 2015, 87 (10) : 1716 - 1721
  • [2] Treatment response of chronic hepatitis C virus infection with pegylated-interferon and ribavirin
    Humphris, J. L.
    Ngu, M. C.
    Lee, A. U.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A331 - A331
  • [3] Effectiveness of sofosbuvir/pegylated-interferon plus ribavirin in treatment of hepatitis C virus genotype 4 patients
    Abdel-Moneim, Adel
    Abood, Alaa
    Abdel-Gabaar, Mohamed
    Zanaty, Mohamed I.
    Ramadan, Mohamed
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2018, 4 (03) : 191 - 196
  • [4] Pegylated interferon and ribavirin therapy for chronic hepatitis C virus genotype 4 infection
    Legrand-Abravanel, F
    Nicot, F
    Boulestin, A
    Sandres-Sauné, K
    Vinel, JP
    Alric, L
    Izopet, J
    JOURNAL OF MEDICAL VIROLOGY, 2005, 77 (01) : 66 - 69
  • [5] Chronic hepatitis C virus genotype 6 infection: Response to pegylated interferon and ribavirin
    Fung, James
    Lai, Ching-Lung
    Hung, Ivan
    Young, John
    Cheng, Charles
    Wong, Danny
    Yuen, Man-Fung
    JOURNAL OF INFECTIOUS DISEASES, 2008, 198 (06): : 808 - 812
  • [6] Combination of sofosbuvir, pegylated-interferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: a systematic review and meta-analysis
    Fardin Dolatimehr
    Hamidreza Karimi-Sari
    Mohammad Saeid Rezaee-Zavareh
    Seyed Moayed Alavian
    Bita Behnava
    Mohammad Gholami-Fesharaki
    Heidar Sharafi
    DARU Journal of Pharmaceutical Sciences, 25
  • [7] Combination of sofosbuvir, pegylated-interferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: a systematic review and meta-analysis
    Dolatimehr, Fardin
    Karimi-Sari, Hamidreza
    Rezaee-Zavareh, Mohammad Saeid
    Alavian, Seyed Moayed
    Behnava, Bita
    Gholami-Fesharaki, Mohammad
    Sharafi, Heidar
    DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 25
  • [8] Pegylated interferon and ribavirin treatment for hepatitis C virus infection
    Palumbo, Emilio
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2011, 2 (01) : 39 - 45
  • [9] Pegylated interferon with ribavirin therapy for chronic infection with the hepatitis C virus
    Foster, GR
    EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (05) : 685 - 691
  • [10] Hepatitis C Virus Genotype 1: How Genetic Variability of the Core Protein Affects the Response to Pegylated-Interferon and Ribavirin Therapy
    Alhamlan, F. S.
    Al-Ahdal, M. N.
    Khalaf, N. Z.
    Abdo, A. A.
    Sanai, F. M.
    Al-Ashgar, H. I.
    ElHefnawi, M.
    Zaid, A.
    Al-Qahtani, A. A.
    JOURNAL OF MEDICAL VIROLOGY, 2014, 86 (02) : 224 - 234
12345